Aurenza Health
Conditions We Review

Periodontal regeneration produced one of 2025's most notable cell therapy trials.

Dental applications rarely make regenerative medicine headlines, which is a shame, because the periodontal research is among the cleanest in the field: randomized, placebo-controlled, with millimeters of measured tissue as the endpoint.

Here is what the newest multicenter trial found, what the pooled literature adds, and where this does and does not apply.

Aurenza does not claim that regenerative medicine treats, cures, or reverses periodontal disease or any dental condition.

Free consultation with a care consultant, many of our care consultants are registered nurses. No sales reps. No receptionist.

What the Research Shows

Dental applications rarely make regenerative medicine headlines, which is a shame, because the periodontal research is among the cleanest in the field: randomized, saline-controlled, with millimeters of measured tissue as the endpoint.

A multicenter randomized clinical trial in Signal Transduction and Targeted Therapy, a Nature Portfolio journal (2025), studied injections of allogeneic dental pulp stem cells in 132 patients with chronic periodontitis across two centers, against saline control. The full open-access results: the injection was safe, produced greater improvement in bone defect depth than saline, and in more severe stage III periodontitis delivered significantly better attachment outcomes, a 1.67 millimeter improvement versus 1.03 with saline, through a non-invasive injection where current regenerative dentistry is typically surgical.

The pooled literature agrees on direction: a 2023 meta-analysis in BMC Oral Health of five randomized trials covering 118 patients found significantly better clinical attachment level with cell-based therapy, a 2025 GRADE-rated meta-analysis of ten clinical trials found significant improvements in probing depth, attachment level, and intrabony defect measures, and earlier pooled analyses in the Journal of Periodontal Research and of periodontal cell therapy broadly reached consistent conclusions.

The Honest Line

This is early, encouraging, and specific, and the strongest new data comes from one country's centers and needs replication at scale, which the trial authors themselves state. The gains are counted in millimeters, meaningful in periodontal disease and to be understood at that scale, and one systematic review of orally derived stem cells found that when only the lowest-risk-of-bias trials were pooled, the attachment advantage lost statistical significance, which is exactly the kind of result a serious reader deserves disclosed. No study shows a guarantee it works every time, or that it will work for you, and nothing replaces the unglamorous foundation: scaling, root planing, hygiene, and smoking cessation remain the load-bearing wall, with every trial above studying cells alongside standard periodontal care.

Why This Is Exactly Where a Candidacy Review Comes In

Periodontal disease is also a chronic inflammatory condition with documented ties to cardiovascular and metabolic health, which is the honest reason it belongs in a whole-person baseline review at all, whether or not any dental procedure ever enters the conversation. Every trial above produced its results in selected patients who met specific criteria. That is the gap between "documented in research" and "right for you," and it is the gap a candidacy review exists to close. Before anything is recommended, your bloodwork, biomarkers, imaging, and history are reviewed by a physician panel to establish whether you are actually in the population the research describes. If the picture supports moving forward, you will know exactly why. If it does not, you will be told that, plainly. That is where to start.

Free consultation with a care consultant, many of our care consultants are registered nurses. No sales reps. No receptionist.

What Your Candidacy Review Covers

Your periodontal status and dental records, including staging if your dentist has assessed it.

Your inflammatory markers, which periodontal disease can contribute to systemically.

Metabolic status, since diabetes and gum disease aggravate each other in both directions.

Smoking status, the single largest modifiable factor in periodontal outcomes.

Physician panel review, in coordination with your own dental providers.

What to Ask Any Provider

What stage is my periodontal disease, on what examination? Which trials are you citing, and does my stage match their patients? What exactly is being injected, at what verified cell count? Is standard periodontal therapy part of the plan, and who performs it? What would make me a poor candidate?

The Honest Limits

Individual results cannot be predicted or guaranteed. These applications are not FDA approved for dental or periodontal conditions, and any coordinated procedure takes place in Mexico under COFEPRIS regulation. Regular dental care with your own providers remains the foundation of periodontal health.

Free consultation with a care consultant, many of our care consultants are registered nurses. No sales reps. No receptionist.

Free consultation with a care consultant, many of whom are registered nurses. No sales reps. No receptionist.